Liofilizzato · 5 mg / vial Tesamorelin 5 mg / vial — Flacone di peptide verificato HPLC

Growth & Anabolic 5 mg / vial

Tesamorelin 5mg — Stabilized GHRH(1-44) Analog

Q: What is Tesamorelin?

Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH 1-44) with a trans-3-hexenoyl group attached to the N-terminus. The hexenoyl modification protects against DPP-4 degradation, dramatically extending the peptide's half-life relative to native GHRH. CAS 218949-48-5.

Q: How is Tesamorelin different from Sermorelin and CJC-1295?

Sermorelin is GHRH(1-29) — the shortest active GHRH fragment, with a very short half-life. CJC-1295 (No DAC) is a substituted GHRH(1-29) analog with four amino acid changes for stability. Tesamorelin is GHRH(1-44) — the full-length GHRH with N-terminal hexenoyl protection. Tesamorelin shows the longest duration of action of the three at clinical doses.

Q: What is the standard Tesamorelin dose?

Common protocols use 1-2 mg per subcutaneous injection, once daily before bed. A 5mg vial reconstituted with 2mL bacteriostatic water yields 250 mcg per 0.1mL, so a 1mg dose equals 0.4mL (40 units on a U-100 insulin syringe). Cycle length typically runs 12-26 weeks with periodic breaks.

Q: How is Tesamorelin tested?

Each Tesamorelin lot is HPLC-tested to ≥99% purity, confirmed by ESI mass spectrometry against the theoretical 5,135.85 Da molecular weight, and endotoxin-tested by LAL to <0.5 EU/mg. ISO 17025-accredited third-party labs perform the testing; the per-lot COA ships with your order.

Q: How do I store Tesamorelin?

Lyophilized Tesamorelin is best stored at -20°C protected from light; it is stable refrigerated at 2-8°C for shorter periods. After reconstitution with bacteriostatic water, refrigerate at 2-8°C and use within 14-21 days. Do not freeze the reconstituted solution.

N-terminal hexenoyl modification · Extended action · DPP-4-resistant GHRH

Premium Grade Out of Stock

Stabilized analog of human GHRH(1-44) with N-terminal hexenoyl modification — extended action.

Numero CAS: 218949-48-5
Peso molecolare: 5 135.85 Da
Purezza: ≥ 99.0% (HPLC)
Conservazione: −20 °C, liofilizzato

Sequenza aminoacidica trans-3-hexenoyl-GHRH(1-44)-NH2

Scegli il Suo kit

1 flacone $35 /flacone $35 totale Più popolare 3 flaconi $25 /flacone $75 totale Miglior rapporto qualità-prezzo 10 flaconi $18 /flacone $180 totale

Gratuita oltre $59$7.99 negli USA (48h) · $14.99 nel mondo (5 giorni lavorativi)

Imballaggio discretoBusta termica neutra, nessun nome del composto all'esterno.

Certificato di analisi

Rapporto analitico per lotto — HPLC, ESI-MS, endotossina LAL, metalli pesanti, sterilità

Lotto correnteTES661

Rilasciato2026-04-07

Purezza HPLC99.53%

Endotossina (LAL)Superato · < 0,5 EU/mg

Leggi il COA completo Visualizza tutti i risultati di laboratorio

Informazioni su Tesamorelin

Buy Tesamorelin 5mg at IGF1 Shop. Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone with a trans-3-hexenoyl moiety attached to the N-terminus, protecting against DPP-4 enzymatic degradation. This stabilization extends the half-life and the duration of GH release beyond what unmodified GHRH offers. Each Tesamorelin 5mg vial is HPLC-verified at ≥99% purity, ESI mass-spec confirmed, and accompanied by a per-lot Certificate of Analysis from an ISO 17025-accredited lab.

Conosciuto anche come: Tesamorelin · TH9507 · Stabilized GHRH analog

Tesamorelin — Meccanismo e specifiche

Tesamorelin is a synthetic 44-amino acid analog of human growth hormone-releasing hormone with a trans-3-hexenoyl moiety attached to the N-terminus, protecting against DPP-4 degradation. Currently out of stock — restock expected within 4 weeks.

Qualità e criteri di rilascio

Ogni lotto di Tesamorelin viene rilasciato solo dopo aver superato l'HPLC in fase inversa (≥ 99% purezza in area a 220 nm rispetto a uno standard di riferimento), la conferma del peso molecolare per spettrometria di massa ESI e il test dell'endotossina con Limulus Amebocyte Lysate (LAL) al di sotto di 0,5 EU/mg. Il Certificato di analisi specifico per lotto è fornito con l'ordine e disponibile su richiesta prima dell'acquisto.

FAQ

Tesamorelin — Domande frequenti

What is Tesamorelin?

Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH 1-44) with a trans-3-hexenoyl group attached to the N-terminus. The hexenoyl modification protects against DPP-4 degradation, dramatically extending the peptide's half-life relative to native GHRH. CAS 218949-48-5.

How is Tesamorelin different from Sermorelin and CJC-1295?

Sermorelin is GHRH(1-29) — the shortest active GHRH fragment, with a very short half-life. CJC-1295 (No DAC) is a substituted GHRH(1-29) analog with four amino acid changes for stability. Tesamorelin is GHRH(1-44) — the full-length GHRH with N-terminal hexenoyl protection. Tesamorelin shows the longest duration of action of the three at clinical doses.

What is the standard Tesamorelin dose?

Common protocols use 1-2 mg per subcutaneous injection, once daily before bed. A 5mg vial reconstituted with 2mL bacteriostatic water yields 250 mcg per 0.1mL, so a 1mg dose equals 0.4mL (40 units on a U-100 insulin syringe). Cycle length typically runs 12-26 weeks with periodic breaks.

How is Tesamorelin tested?

Each Tesamorelin lot is HPLC-tested to ≥99% purity, confirmed by ESI mass spectrometry against the theoretical 5,135.85 Da molecular weight, and endotoxin-tested by LAL to <0.5 EU/mg. ISO 17025-accredited third-party labs perform the testing; the per-lot COA ships with your order.

How do I store Tesamorelin?